Optimised topical delivery of 5-fluorouracil
Skin cancer is the most widely diagnosed form of cancer and it is split in to non-melanoma skin cancer (NMSC) and cutaneous malignant melanoma (CMM). Cutaneous melanoma has a high propensity for malignancy and it has the highest mortality rate of all skin cancers (de Gruijl, 1999:2004). The first li...
Main Author: | Chinembiri, Tawona Nyasha |
---|---|
Language: | en |
Published: |
North-West University
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10394/9000 |
Similar Items
-
Optimised topical delivery of 5-fluorouracil
by: Chinembiri, Tawona Nyasha
Published: (2013) -
Transdermal delivery of 5-Fluorouracil with PheroidTM technology / C.P. van Dyk
by: Van Dyk, Christina Petronella
Published: (2009) -
Transdermal delivery of 5-Fluorouracil with PheroidTM technology / C.P. van Dyk
by: Van Dyk, Christina Petronella
Published: (2009) -
Comparative Study of Marketed and Novel Colloidal Formulation for Topical Delivery of 5-Fluorouracil to Skin Cancer Cells: Ex-Vivo Release Study and Cytotoxicity Analysis
by: Kaur, C.D, et al.
Published: (2022) -
Eruptive keratoacanthomas secondary to topical 5-fluorouracil application
by: Estefanía Cruzval-O'Reilly, MD, et al.
Published: (2021-10-01)